TradeFlare's AI research teams analysed VKTX on 4 market nights between July 10, 2026 and July 29, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| July 29, 2026 | BUY | $33.86 | $37.00 / $28.05 | +0.2% | +2.8% | The bullish fundamental and sentiment outlook, combined with a technical oversold bounce signal, suggests a potential recovery over a few weeks. |
| July 28, 2026 | BUY | $34.87 | $41.07 / $29.64 | -2.7% | +0.9% | The bullish fundamental and sentiment catalysts for VKTX are expected to play out over several weeks as clinical trial data is further digested and analyst price targets are considered. |
| July 27, 2026 | BUY | $34.79 | $38.46 / $28.89 | -6.5% | -4.7% | The setup suggests a short-term bounce opportunity driven by technical oversold conditions and positive fundamental/sentiment, but the high risk profile necessitates a shorter time horizon. |
| July 10, 2026 | BUY | $41.14 | $55.52 / $34.97 | -4.6% | -11.8% | The post-earnings drift signal suggests a multi-week trend potential. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.